Chris Francis sold $150k of WVE
See Remarks at Wave Life Sciences Ltd.. 9,375 shares at an average of $16.03, traded Jan 2, 2026, filed Jan 6, 2026.
Score components
- +15RoleOfficer
- +11Trade size$150k at market
- +10Share of holdings soldSold 27% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.8%, 3m -53.1%, 6m -57.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-005195, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | MOption exercise Ordinary Shares10b5-1 | +9,375 | $3.14 | $29k | 34,375 | Jan 6, 2026 |
| Jan 2, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -8,080 | $15.92 | $129k | 26,295 | Jan 6, 2026 |
| Jan 2, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -1,295 | $16.70 | $22k | 25,000 | Jan 6, 2026 |
| Jan 2, 2026 | MOption exercise Share Option (right to buy)derivative10b5-1 | -9,375 | $0.00 | $0 | 0 | Jan 6, 2026 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Wave Life Sciences Ltd. | Adrian Rawcliffe director | $67k 12,700 shares | -100% | |
| 15Weak | Wave Life Sciences Ltd. | Ken Takanashi director | $23k 3,864 shares | -16% | |
| 10Weak | Wave Life Sciences Ltd. | Aik Na Tan director | $2,596 432 shares | -2% | |
| 6Weak | Wave Life Sciences Ltd. | Heidi L Wagner director | $42k 7,000 shares | -13% | |
| 49Moderate | WVEbuy Wave Life Sciences Ltd. | Ra Capital Management, L.p. director, owner | $55M 8,772,496 shares | +48% | |
| 8Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $500k 33,194 shares | -42% | |
| 51Moderate | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $141k 10,480 shares | -4% | |
| 35Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $25k 1,883 shares | -3% | |
| 44Moderate | Wave Life Sciences Ltd. | Kyle Moran Chief Financial Officer | $48k 3,588 shares | -3% | |
| 36Weak | Wave Life Sciences Ltd. | Chandra Vargeese See Remarks | $43k 3,228 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.